Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

CONCLUSIONS: Based on very low- or low-quality evidence using the GRADE approach and overall low risk of bias, the current evidence shows that the empirical routine addition of antiGP treatment, namely glycopeptides, does not improve the outcomes of febrile neutropenic patients with cancer.
PMID: 28577308 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - June 3, 2017 Category: General Medicine Authors: Beyar-Katz O, Dickstein Y, Borok S, Vidal L, Leibovici L, Paul M Tags: Cochrane Database Syst Rev Source Type: research